A detailed history of King Luther Capital Management Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, King Luther Capital Management Corp holds 17,172 shares of NVO stock, worth $1.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,172
Previous 28,171 39.04%
Holding current value
$1.5 Million
Previous $4.02 Million 49.17%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$119.07 - $145.42 $1.31 Million - $1.6 Million
-10,999 Reduced 39.04%
17,172 $2.04 Million
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $363,221 - $434,853
2,960 Added 11.74%
28,171 $4.02 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $24,608 - $32,756
241 Added 0.97%
25,211 $3.24 Million
Q4 2023

Feb 09, 2024

SELL
$87.78 - $105.45 $3,511 - $4,218
-40 Reduced 0.16%
24,970 $2.58 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $1.68 Million - $3.68 Million
18,431 Added 280.15%
25,010 $2.27 Million
Q2 2023

Aug 10, 2023

BUY
$155.98 - $172.65 $24,644 - $27,278
158 Added 2.46%
6,579 $1.06 Million
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $26,335 - $31,668
-199 Reduced 3.01%
6,421 $1.02 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $32,713 - $43,170
319 Added 5.06%
6,620 $895,000
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $326,619 - $400,836
-3,428 Reduced 35.23%
6,301 $628,000
Q2 2022

Aug 11, 2022

BUY
$103.24 - $121.81 $668,375 - $788,597
6,474 Added 198.89%
9,729 $1.08 Million
Q1 2022

May 11, 2022

BUY
$93.1 - $112.54 $106,971 - $129,308
1,149 Added 54.56%
3,255 $361,000
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $79,963 - $97,644
-834 Reduced 28.37%
2,106 $236,000
Q3 2021

Nov 10, 2021

SELL
$84.42 - $106.62 $3,292 - $4,158
-39 Reduced 1.31%
2,940 $282,000
Q2 2021

Aug 13, 2021

BUY
$67.66 - $84.76 $201,559 - $252,500
2,979 New
2,979 $250,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.